Merck (NYSE: MRK) announced that the Hart-Scott-Rodino Act waiting period for its acquisition of Terns Pharmaceuticals (NASDAQ: TERN) expired on ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions